Search

Your search keyword '"Limmroth, Volker"' showing total 706 results
Start Over Author "Limmroth, Volker"
706 results on '"Limmroth, Volker"'

1. Autorinnen und Autoren

Author

Andresen, Viola, primary, Berlit, Peter, additional, Bingel, Ulrike, additional, Burger, Michael, additional, Daniels, Christine, additional, Deuschl, Günther, additional, Diener, Cristoph, additional, Eckstein, Hans-Henning, additional, Elger, Christian E., additional, Erbguth, Frank, additional, Eyüpoglu, Ilker, additional, Faissner, Simon, additional, Fink, Gereon R., additional, Forsting, Michael, additional, Gold, Ralf, additional, Goldbrunner, Roland, additional, Heuß, Dieter F., additional, Jeub, Monika, additional, Jordan, Berit, additional, Kastrup, Oliver, additional, Klein, Matthias, additional, Kleine-Borgmann, Julian, additional, Kovac, Stjepana, additional, Kuramatsu, Joji B., additional, Layer, Peter, additional, Lehmann, Helmar C., additional, Limmroth, Volker, additional, Neuneier, Janina, additional, Nickenig, Georg, additional, Onur, Özgür, additional, Pfister, Hans-Walter, additional, Schlamann, Marc, additional, Schneider-Gold, Christiane, additional, Scholz, Martin, additional, Schwab, Stefan, additional, Sommer, Christof-Matthias, additional, Steinbach, Joachim, additional, Strupp, Michael, additional, Schassen, K. Henrike von, additional, Voß, Martin, additional, Wallesch, Claus-Werner, additional, and Zierz, Stephan, additional

Published
2024
Full Text
View/download PDF

5. Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)

Author

Wiendl, Heinz, Gold, Ralf, Berger, Thomas, Derfuss, Tobias, Linker, Ralf, Mäurer, Mathias, Stangel, Martin, Aktas, Orhan, Baum, Karl, Berghoff, Martin, Bittner, Stefan, Chan, Andrew, Czaplinski, Adam, Deisenhammer, Florian, Di Pauli, Franziska, Du Pasquier, Renaud, Enzinger, Christian, Fertl, Elisabeth, Gass, Achim, Gehring, Klaus, Gobbi, Claudio, Goebels, Norbert, Guger, Michael, Haghikia, Aiden, Hartung, Hans‑Peter, Heidenreich, Fedor, Hoffmann, Olaf, Hunter, Zoë R., Kallmann, Boris, Kleinschnitz, Christoph, Klotz, Luisa, Leussink, Verena, Leutmezer, Fritz, Limmroth, Volker, Lünemann, Jan D., Lutterotti, Andreas, Meuth, Sven G., Meyding-Lamadé, Uta, Platten, Michael, Rieckmann, Peter, Schmidt, Stephan, Tumani, Hayrettin, Weber, Martin S., Weber, Frank, Zettl, Uwe K., Ziemssen, Tjalf, and Zipp, Frauke

Published
2021
Full Text
View/download PDF

7. Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation

Author

Pfeuffer, Steffen, Schmidt, Rene, Straeten, Frederike Anne, Pul, Refik, Kleinschnitz, Christoph, Wieshuber, Marinus, Lee, De-Hyung, Linker, Ralf A., Doerck, Sebastian, Straeten, Vera, Windhagen, Susanne, Pawlitzki, Marc, Aufenberg, Christoph, Lang, Michael, Eienbroeker, Christian, Tackenberg, Björn, Limmroth, Volker, Wildemann, Brigitte, Haas, Jürgen, Klotz, Luisa, Wiendl, Heinz, Ruck, Tobias, and Meuth, Sven G.

Published
2019
Full Text
View/download PDF

8. Alemtuzumab as rescue therapy in a cohort of 50 relapsing–remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study

Author

Huhn, Konstantin, Bayas, Antonios, Doerck, Sebastian, Frank, Benedikt, Gerbershagen, Kathrin, Hellwig, Kerstin, Kallmann, Boris, Kleinschnitz, Christoph, Kleiter, Ingo, Lee, De-Hyung, Limmroth, Volker, Mäurer, Mathias, Meuth, Sven, Rieckmann, Peter, Ruck, Tobias, Gold, Ralf, and Linker, Ralf A.

Published
2018
Full Text
View/download PDF

11. Adressen

Author

Bassetti, Claudio, primary, Bopp-Kistler, Irene, additional, Bosshard, Georg, additional, Cassai, Lilian de, additional, Diener, Suzie, additional, Felbecker, Ansgar, additional, Früh, Severin, additional, Göhl, Kristina, additional, Hägele-Link, Stefan, additional, Herwig, Uwe, additional, Kägi, Georg, additional, Limmroth, Volker, additional, Meyer-Heim, Tatjana, additional, Müri, René, additional, Oberholzer, Michael, additional, Seeger, Rolf, additional, Tettenborn, Barbara, additional, Unschuld, Paul G., additional, Welz, Dieter, additional, and Zieglgänsberger, Dominik, additional

Published
2019
Full Text
View/download PDF

12. Leben mit Demenz

Author

Felbecker, Ansgar, primary, Limmroth, Volker, additional, Bopp-Kistler, Irene, additional, Meyer-Heim, Tatjana, additional, Bosshard, Georg, additional, Seeger, Rolf, additional, Welz, Dieter, additional, and Herwig, Uwe, additional

Published
2019
Full Text
View/download PDF

13. Einleitung

Author

Felbecker, Ansgar, primary, Limmroth, Volker, additional, and Tettenborn, Barbara, additional

Published
2019
Full Text
View/download PDF

14. Vorwort

Author

Felbecker, Ansgar, primary, Limmroth, Volker, additional, and Tettenborn, Barbara, additional

Published
2019
Full Text
View/download PDF

39. Demenzen

Author

Diener, Hans-Christoph, Limmroth, Volker, Diener, Hans-Christoph, and Limmroth, Volker

Published
2002
Full Text
View/download PDF

40. Schwindel

Author

Diener, Hans-Christoph, Limmroth, Volker, Diener, Hans-Christoph, and Limmroth, Volker

Published
2002
Full Text
View/download PDF

49. <scp>COVID</scp> ‐19 Vaccine‐Associated Cerebral Venous Thrombosis in Germany

Author

Schulz, Jörg B, Berlit, Peter, Steinmetz, Helmuth, Thiele, Thomas, Kurth, Tobias, Group, German Society of Neurology SARS-CoV-2 Vaccination Study, Alonso, Angelika, Bartsch, Thorsten, Baumsteiger, Christoph, Bode, Felix, Cangür, Hakan, Daffertshofer, Michael, Diener, Hans-Christoph, Dafotakis, Manuel, Dieterich, Marianne, Fabian, Friederike, Fousse, Mathias, Godau, Jana, Grond, Martin, Günther, Albrecht, Gutschalk, Alexander, Hagemann, Georg, Hartmann, Corinna, Gerloff, Christian, Hilker-Roggendorf, Rüdiger, Höglinger, Günter, Ikenberg, Benno, Ismail, Fatme Seval, Jesse, Sarah, Kallmünzer, Bernd, Kern, Rolf, Klietz, Martin, Knauß, Samuel, Knier, Benjamin, Greinacher, Andreas, Limmroth, Volker, Mengel, Annerose, Meyne, Johannes, Morgenthaler, Martin, Müller, Matthias, Nagel, Simon, Niels, Ralf Dittrich, Onur, Oezguer A, Pelz, Johann, Plenge, Johannes, Klein, Christine, Poli, Sven, Roth, Christian, Röther, Joachim, Saß, Christian, Schönenberger, Silvia, Schubert, Roger, Simon, Ole, Agaplesion, Ina Specht, Sperfeld, Anne, Spreer, Annette, Petzold, Gabor C, Steinbrecher, Andreas, Steiner, Jochen, Stetefeld, Henning, Trendelenburg, George, Vatankhah, Nils Bijan, Wahl, Christoph Michael, Wartenberg, Katja, Witt, Karsten, Wittstock, Matthias, Wolf, Björn, Piccininni, Marco, Wolf, Joachim, Zimmermann, Julian, and Röhrig, Rainer

Subjects
Male, Pediatrics, Neurology, Medizin, etiology [Intracranial Thrombosis], BNT162 vaccine, epidemiology [Cerebral Hemorrhage], Rate ratio, etiology [Ischemic Stroke], Germany, Surveys and Questionnaires, epidemiology [Ischemic Stroke], epidemiology [Venous Thrombosis], Research Articles, etiology [Venous Thrombosis], Venous Thrombosis, Aged, 80 and over, education.field_of_study, Incidence, Incidence (epidemiology), Age Factors, Middle Aged, etiology [Cerebral Hemorrhage], Vaccination, Venous thrombosis, Female, Research Article, Adult, medicine.medical_specialty, COVID-19 Vaccines, Coronavirus disease 2019 (COVID-19), Population, epidemiology [Germany], Young Adult, Sex Factors, ChAdOx1 nCoV-19, medicine, adverse effects [COVID-19 Vaccines], Humans, ddc:610, education, BNT162 Vaccine, Cerebral Hemorrhage, Ischemic Stroke, Aged, epidemiology [Intracranial Thrombosis], business.industry, medicine.disease, Confidence interval, ChAdOx1 COVID-19 vaccine, Neurology (clinical), Intracranial Thrombosis, business
Abstract

OBJECTIVE We aimed to estimate the incidence of cerebral sinus and venous thrombosis (CVT) within 1 month from first dose administration and the frequency of vaccine-induced immune thrombotic thrombocytopenia (VITT) as the underlying mechanism after vaccination with BNT162b2, ChAdOx1, and mRNA-1273, in Germany. METHODS A web-based questionnaire was e-mailed to all departments of neurology. We requested a report of cases of CVT occurring within 1 month of a COVID-19 vaccination. Other cerebral events could also be reported. Incidence rates of CVT were calculated by using official statistics of 9 German states. RESULTS A total of 45 CVT cases were reported. In addition, 9 primary ischemic strokes, 4 primary intracerebral hemorrhages, and 4 other neurological events were recorded. Of the CVT patients, 35 (77.8%) were female, and 36 (80.0%) were younger than 60 years. Fifty-three events were observed after vaccination with ChAdOx1 (85.5%), 9 after BNT162b2 (14.5%) vaccination, and none after mRNA-1273 vaccination. After 7,126,434 first vaccine doses, the incidence rate of CVT within 1 month from first dose administration was 0.55 (95% confidence interval [CI] = 0.38-0.78) per 100,000 person-months (which corresponds to a risk of CVT within the first 31 days of 0.55 per 100,000 individuals) for all vaccines and 1.52 (95% CI = 1.00-2.21) for ChAdOx1 (after 2,320,535 ChAdOx1 first doses). The adjusted incidence rate ratio was 9.68 (95% CI = 3.46-34.98) for ChAdOx1 compared to mRNA-based vaccines and 3.14 (95% CI = 1.22-10.65) for females compared to non-females. In 26 of 45 patients with CVT (57.8%), VITT was graded highly probable. INTERPRETATION Given an incidence of 0.02 to 0.15 per 100,000 person-months for CVT in the general population, these findings point toward a higher risk for CVT after ChAdOx1 vaccination, especially for women. ANN NEUROL 2021;90:627-639.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results